| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035576702 |
| P356 | DOI | 10.2165/00002512-199915050-00004 |
| P698 | PubMed publication ID | 10600044 |
| P5875 | ResearchGate publication ID | 12701460 |
| P2093 | author name string | Agüero-Torres H | |
| Fratiglioni L | |||
| De Ronchi D | |||
| P2860 | cites work | Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. | Q32054539 |
| The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data | Q33190548 | ||
| A community based study of the incidence of dementia in subjects aged 85 years and over | Q33734704 | ||
| Prevalence of dementia in an elderly rural population: effects of age, sex, and education | Q33735314 | ||
| Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians | Q33862115 | ||
| Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study | Q34063247 | ||
| Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. | Q36843772 | ||
| Epidemiology of the dementias: recent developments and new approaches | Q36891191 | ||
| Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias | Q37090845 | ||
| A Community-Based Study of Dementia: The Rotterdam Elderly Study | Q39240699 | ||
| Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex, and education | Q39245332 | ||
| A three-year follow-up study of age-related dementia in an urban area of Beijing | Q39254801 | ||
| Prevalence of dementia in the 'oldest old' of a Dutch community | Q39257388 | ||
| The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings | Q57782178 | ||
| Prevalence of dementia in a Norwegian sample aged 75 years and over and living at home | Q68103298 | ||
| Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975 | Q69618069 | ||
| [Prevalence and incidence of dementia diseases in the elderly population. Results of a population-related longitudinal study in Mannheim] | Q69759676 | ||
| Epidemiology of vascular dementia | Q71524679 | ||
| Is senile dementia "age-related" or "ageing-related"?--evidence from meta-analysis of dementia prevalence in the oldest old | Q71756210 | ||
| Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France | Q72167024 | ||
| Aging: a global issue | Q73818226 | ||
| The Gospel Oak Study stage II: the diagnosis of dementia in the community | Q39265298 | ||
| Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy | Q39267017 | ||
| The need for research on dementia in developing countries | Q39369174 | ||
| Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study | Q39402549 | ||
| Sources of variability in prevalence rates of Alzheimer's disease | Q39418084 | ||
| Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm | Q39465608 | ||
| The prevalence of dementia: a quantitative integration of the literature | Q39692741 | ||
| The prevalence of dementia in the elderly: a review | Q40680179 | ||
| Dementia and ethnicity. | Q40849904 | ||
| Five-year incidence and prediction of dementia and cognitive decline in a population sample of women aged 70-79 at baseline. | Q40873038 | ||
| Why are stroke patients prone to develop dementia? | Q41364428 | ||
| Evaluation of risk factors for Alzheimer's disease in elderly east Africans | Q41640588 | ||
| Dementia among the elderly in a rural Korean community | Q43485959 | ||
| Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. | Q44368769 | ||
| The Gospel Oak Study stage III: the incidence of dementia | Q44545850 | ||
| Prevalence of dementia in old age: clinical diagnoses in subjects aged 95 years and older | Q44890775 | ||
| Prevalence of severe dementia in Finland | Q45127377 | ||
| The incidence of dementia: a meta-analysis | Q45174488 | ||
| Incidence and risk of dementia. The Rotterdam Study | Q45282189 | ||
| Prevalence of dementia in the city of Helsinki | Q47268268 | ||
| The prevalence of dementia among elderly people living in Zaragoza and Liverpool | Q47298012 | ||
| The role of APOE polymorphisms in late-onset dementias | Q48365511 | ||
| Prevalence and etiology of dementia in a Japanese community | Q48473725 | ||
| Prevalence of very mild to severe dementia in Denmark. | Q50560934 | ||
| Incidence of dementia in a population older than 75 years in the United Kingdom. | Q50603924 | ||
| Incidence of dementia in a Munich community sample of the oldest old. | Q50617416 | ||
| Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. | Q50631918 | ||
| Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. | Q50664920 | ||
| Prevalence of dementia in a rural Netherlands population and the influence of DSM-III-R and CAMDEX criteria for the prevalence of mild and more severe forms. | Q50754761 | ||
| The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. | Q50866744 | ||
| The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status. | Q50887276 | ||
| Prevalence of dementia in Chinese elderly in Hong Kong. | Q50892484 | ||
| Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. | Q51001737 | ||
| Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. | Q51990766 | ||
| Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. | Q52000423 | ||
| Dementing disorders in north Italy: prevalence study in Vescovato, Cremona Province. | Q52003654 | ||
| Dementia and cognitive impairment in the oldest old in the community. Prevalence and comorbidity. | Q52016783 | ||
| The prevalence of dementia in Belgium: a population-based door-to-door survey in a rural community. | Q52030042 | ||
| Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. | Q52037686 | ||
| A population-based study of dementia in 85-year-olds. | Q52038432 | ||
| Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool | Q52042222 | ||
| The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group. | Q52047079 | ||
| Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. | Q52048616 | ||
| An epidemiological study of dementia in a rural population of elderly women. | Q52064870 | ||
| The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. | Q52066603 | ||
| Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package. | Q52074619 | ||
| Does the incidence of age psychosis decrease? A prospective, longitudinal study of a complete population investigated during the 25-year period 1947-1972: the Lundby study. | Q52102734 | ||
| An epidemiological study of dementia in a rural community in Kerala, India. | Q53213103 | ||
| A population-based study on the incidence of dementia disorders between 85 and 88 years of age. | Q53215317 | ||
| Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study | Q53295392 | ||
| P433 | issue | 5 | |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 365-375 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Drugs & Aging | Q5308946 |
| P1476 | title | Worldwide prevalence and incidence of dementia | |
| P478 | volume | 15 |
| Q93353570 | A Longitudinal Study of Peripheral and Central Auditory Function in Alzheimer's Disease and in Mild Cognitive Impairment |
| Q50706594 | A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments. |
| Q79295155 | A new approach to the qualitative evaluation of functional disability in dementia |
| Q90604221 | A review of clinical treatment considerations of donepezil in severe Alzheimer's disease |
| Q34747831 | A summary risk score for the prediction of Alzheimer disease in elderly persons |
| Q91676632 | A systematic review of the use of virtual reality and its effects on cognition in individuals with neurocognitive disorders |
| Q36426738 | Accounting for the relationship between low education and dementia: a twin study |
| Q35196321 | Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein |
| Q39604928 | Air pollution and brain damage |
| Q36744204 | Altered expression of RNA splicing proteins in Alzheimer's disease patients: evidence from two microarray studies |
| Q85013370 | Alzheimer disease |
| Q36026972 | Alzheimer's and dementia in the oldest-old: a century of challenges |
| Q38163914 | Alzheimer's as a metabolic disease |
| Q53326422 | Alzheimer's disease is associated with a low prevalence of hypertension. |
| Q51922260 | Alzheimer's disease-associated disability: an ICF approach. |
| Q47096860 | Analysis of the Retinal Nerve Fiber Layer Thickness in Alzheimer Disease and Mild Cognitive Impairment |
| Q45002702 | Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries |
| Q37272238 | Association between mid-life marital status and cognitive function in later life: population based cohort study |
| Q35756752 | Association of dyslipidemia and effects of statins on nonmacrovascular diseases |
| Q37317675 | Association of higher diastolic blood pressure levels with cognitive impairment. |
| Q34154473 | Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease |
| Q53244060 | Autonomy, authenticity, or best interest: everyday decision-making and persons with dementia. |
| Q43978905 | Beliefs about Alzheimer's disease in Britain. |
| Q37273675 | Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood |
| Q35043147 | Blood Pressure Variability and Cognitive Function in the Elderly |
| Q34646830 | Burden of disease due to dementia in the elderly population of Korea: present and future |
| Q34787474 | CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study |
| Q35236838 | CSF tau and β-amyloid as biomarkers for mild cognitive impairment. |
| Q53405117 | Cardiac autonomic modulation and cognitive status in Alzheimer's disease. |
| Q36582769 | Cardiac risk factors and potential treatments in Alzheimer's disease |
| Q24240209 | Case/care management approaches to home support for people with dementia |
| Q37211768 | Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia |
| Q53273836 | Children of Alzheimer patients: an overview. |
| Q36039851 | Children of persons with Alzheimer disease: what does the future hold? |
| Q35170124 | Choice Inconsistencies Among the Elderly: Evidence from Plan Choice in the Medicare Part D Program |
| Q37857031 | Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project. |
| Q34324763 | Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia |
| Q51981444 | Cognitive impairment and carotid atherosclerosis in a general Italian midlife and old population. |
| Q48606995 | Cognitive telerehabilitation in mild cognitive impairment, Alzheimer's disease and frontotemporal dementia: A systematic review |
| Q85961131 | Cortisol, HDL-c, VLDL-c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia |
| Q93353557 | Current Perspectives and Mechanisms of Relationship between Intestinal Microbiota Dysfunction and Dementia: A Review |
| Q39695927 | Dementia and depressive symptoms as predictors of home help utilization among the oldest old: population-based study in an urban area of Sweden |
| Q84042440 | Dementia and poor surgical outcomes: reinventing the wheel or providing empirical evidence? |
| Q34387545 | Dementia in patients undergoing long-term dialysis: aetiology, differential diagnoses, epidemiology and management |
| Q51917258 | Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity. |
| Q53357923 | Dementia in the USA: state variation in prevalence. |
| Q35945651 | Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population |
| Q44387282 | Dementia: an anthropological perspective |
| Q34634911 | Depression and incident dementia. An 8-year population-based prospective study |
| Q44908766 | Differences in drug therapy between dementia disorders in the Swedish dementia registry: a nationwide study of over 7,000 patients |
| Q52147920 | Diffusion tensor imaging of the hippocampus predicts the risk of dementia; the RUN DMC study. |
| Q30836664 | Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex |
| Q22241448 | Economic considerations in the management of Alzheimer's disease |
| Q39823141 | Education and use of dementia drugs: a register-based study of over 600,000 older people |
| Q37160197 | Effect of smoking and time on cognitive function in the elderly without dementia |
| Q57822469 | Effect of smoking cessation on the risk of dementia: a longitudinal study |
| Q30459046 | Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study |
| Q38433654 | Efficacy and adverse effects of memantine treatment for Alzheimer's disease from randomized controlled trials |
| Q38112886 | Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis |
| Q34079841 | Epidemiology of Dementia among the Elderly in Sub-Saharan Africa |
| Q38907270 | Epilepsy: Asia versus Africa. |
| Q44847650 | Evaluating the prevalence of dementia in hospitalized older adults and effects of comorbid dementia on patients' hospital course |
| Q38809186 | Everyday cognitive functioning and global cognitive performance are differentially associated with physical frailty and chronological age in older Chinese men and women. |
| Q38281498 | Evolution of social networks: the example of obesity |
| Q35014608 | Evolution of the needs of older persons. |
| Q57629694 | Executive Functioning |
| Q42703976 | Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats |
| Q37000143 | Flavanols, mild cognitive impairment, and Alzheimer's dementia |
| Q53407515 | Flavonoid intake and disability-adjusted life years due to Alzheimer's and related dementias: a population-based study involving twenty-three developed countries. |
| Q53480316 | Gait Disorder in a Cohort of Patients With Mild and Moderate Alzheimer's Disease. |
| Q35327053 | Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting |
| Q44801726 | Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism |
| Q37515666 | Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations |
| Q30503996 | Genome scan of age-at-onset in the NIMH Alzheimer disease sample uncovers multiple loci, along with evidence of both genetic and sample heterogeneity |
| Q33838241 | Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE |
| Q56769920 | Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease |
| Q36195892 | Geographical variation in dementia: systematic review with meta-analysis |
| Q37970751 | Health state values for use in the economic evaluation of treatments for Alzheimer's disease |
| Q39817537 | High prevalence of dementia in a Caribbean population. |
| Q38238644 | Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier |
| Q41101780 | Hypertension Severity Is Associated With Impaired Cognitive Performance. |
| Q92584204 | Hypertension and Neuropsychiatric Symptoms in Patients with Drug-Naïve Alzheimer's Disease |
| Q46513263 | Illiteracy and the incidence of Alzheimer's disease in the Yonchon County survey, Korea |
| Q37331853 | Impact of plasma lipids and time on memory performance in healthy elderly without dementia |
| Q36135752 | Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain |
| Q41189702 | Increased risk of dementia among patients with pulmonary tuberculosis: a retrospective population-based cohort study. |
| Q34165716 | Is dementia with Lewy bodies the second most common cause of dementia? |
| Q48589585 | Job satisfaction, work ability and life satisfaction among Finnish anaesthesiologists |
| Q53384045 | Living with a person with Alzheimer's disease: experiences related to everyday occupations. |
| Q37354940 | MRI- and MRS-derived hippocampal correlates of quantitative locomotor function in older adults |
| Q34580641 | Management of patients with cognitive impairment by residential doctors |
| Q35218769 | Memantine: update on the current evidence |
| Q48144788 | Molecular perception of interactions between bis(7)tacrine and cystamine-tacrine dimer with cholinesterases as the promising proposed agents for the treatment of Alzheimer's disease. |
| Q42668185 | Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins |
| Q36310524 | NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease |
| Q45057933 | Net costs of dementia in Sweden - an incidence based 10 year simulation study |
| Q36036269 | Neuropathological Associates of Multiple Cognitive Functions in Two Community-Based Cohorts of Older Adults |
| Q42737932 | Neuroprotective Effect of Ethanol Extract of Leaves of Malva parviflora against Amyloid-β- (Aβ-) Mediated Alzheimer's Disease |
| Q32077061 | Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. |
| Q44404772 | No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease. |
| Q38069506 | Pathway analysis of the human brain transcriptome in disease |
| Q51509795 | Polyneuropathy and dementia in old age: common inflammatory and vascular parameters. |
| Q90569201 | Prescription Drug Use under Medicare Part D: A Linear Model of Nonlinear Budget Sets |
| Q33601845 | Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal |
| Q46352788 | Prevalence of dementia and dementia subtypes among community-dwelling elderly people in northern Nigeria |
| Q37390896 | Prevalence of dementia in Al-Quseir city, Red Sea Governorate, Egypt. |
| Q51953384 | Prevalence of dementia with Lewy bodies in an inpatient psychogeriatric population in Hong Kong Chinese. |
| Q34451813 | Prevalence of the major mental disorders among the Korean elderly |
| Q28066876 | Psychological interventions to improve psychological well-being in people with dementia or mild cognitive impairment: systematic review and meta-analysis protocol |
| Q35996632 | Registered Nurses´ View of Performing Pain Assessment among Persons with Dementia as Consultant Advisors |
| Q35917114 | Relation of Blood Pressure to Cognitive Impairment and Dementia |
| Q50627491 | Risk factors for dementia in central Nigeria. |
| Q40297061 | Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study |
| Q34000911 | Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia |
| Q33742148 | Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease |
| Q53477029 | Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's disease. |
| Q36176965 | Sex, hormones, and Alzheimer's disease |
| Q39771383 | Socio-demographic variation of dementia subtypes in china: Methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and Xian |
| Q39633854 | Staff opinions about the leadership and organisation of municipal dementia care |
| Q46438866 | Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects |
| Q38068021 | Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia |
| Q37160208 | Stroke and memory performance in elderly persons without dementia |
| Q52351629 | Study protocol for Vitality: a proof-of-concept randomised controlled trial of exercise training or complex mental and social activities to promote cognition in adults with chronic stroke. |
| Q47117455 | Systematic review of dementia prevalence 1994 to 2000. |
| Q37763138 | Systematic review of economic evaluations of Alzheimer's disease medications |
| Q35105599 | THE FRAGILITY OF THE FUTURE AND THE TUG OF THE PAST: LONGEVITY IN LATIN AMERICA AND THE CARIBBEAN. |
| Q93480292 | The Alzheimer’s project: HBO Documentary Films and the National Institute on Aging at the NIH. 2009 |
| Q37217996 | The Epidemiology of vascular dementia |
| Q52580255 | The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer's Disease and Other Dementias in the United States. |
| Q38852543 | The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis |
| Q64891767 | The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia. |
| Q36201875 | The age-dependent relation of blood pressure to cognitive function and dementia |
| Q24652703 | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
| Q45884689 | The emerging utility of animal models of chronic neurodegenerative diseases |
| Q44793578 | The prevalence of dementia in a population-based study carried out in Granarolo, Ravenna |
| Q34110370 | The psychosocial burden on spouses of the elderly with stroke, dementia and Parkinson's disease |
| Q37766266 | The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. |
| Q33917017 | The type A behavior pattern and cardiovascular disease as predictors of dementia |
| Q37246161 | The worldwide challenge of the dementias: a role for B vitamins and homocysteine? |
| Q30239789 | Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline |
| Q42693541 | Three-state frailty model for age at onset of dementia and death in Swedish twins |
| Q41656721 | Tooth loss is associated with severe cognitive impairment among older people: findings from a population-based study in Brazil |
| Q36136747 | Toward the validation of functional neuroimaging as a potential biomarker for Alzheimer's disease: implications for drug development |
| Q34989474 | Treatment options: the latest evidence with galantamine (Reminyl). |
| Q37822837 | Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics? |
| Q33640956 | Use of genetic variation as biomarkers for Alzheimer's disease |
| Q34013606 | Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia |
| Q35533115 | Using biomarkers to improve detection of Alzheimer's disease. |
| Q30540165 | Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans |
| Q36021042 | Vascular dementia. Stroke risk and sequelae define therapeutic approaches |
| Q47656339 | Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer's disease. |
| Q33305144 | What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures |
| Q80220901 | [Cost relation between severity of Alzheimer's disease and cognitive and functional impairment] |
| Q53358157 | [Economic impact of Alzheimer's Disease in Brazil: is it possible to improve care and minimize costs?]. |
Search more.